NIDAN — Nidan Laboratories and Healthcare Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Market Cap
IN₹278.00m
Enterprise Value
IN₹334.13m
Revenue
IN₹241.77m

Annual income statement for Nidan Laboratories and Healthcare, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	R2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	222	204	297	243	242
Cost of Revenue
Gross Profit	—	182	266	232	232
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	215	72.2	92.8	61.3	122
Operating Profit	7.15	132	204	181	119
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7.15	33	45.2	48.1	-23.7
Provision for Income Taxes
Net Income After Taxes	7.15	23	26.6	35.4	-32.3
Net Income Before Extraordinary Items
Net Income	7.15	23	26.6	35.4	-32.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	7.15	23	26.6	35.4	-32.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.514	1.66	2.17	2.4	0.722
Dividends per Share